In addition, CurveAlign analysis of the collagen orientation on these tumors revealed that the mammary tumors injected with PAPP-A had a significantly higher frequency of TACS3 regions compared to the control group (Fig. 2h, i). This evidence concerns the gene PAPPA and breast cancer.